{
  "id": 16029541,
  "title": "Roche talks up Phase 3 success rate as it unveils pipeline cuts",
  "url": "https://urgent.news/2026/10/22/roche-talks-up-phase-3-success-rate-as-it-unveils-pipeline-cuts",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-22T10:21:48.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/roche-talks-up-phase-3-success-rate-as-it-unveils-pipeline-cuts/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Where other European pharmas — notably Novartis, Novo and AstraZeneca — have suffered huge late-stage clinical failures this summer, Roche is feeling rather smug. CEO Thomas Schinecker said ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}